January 21, 2013 Issue | Chemical & Engineering News
 
 

Countdown to the 2014 Chemistry Nobel Prize

Events: C&EN reporters, special guests webcast their predictions for the 2014 Nobel Prize in Chemistry. Visit http://cenm.ag/2014chemnobel.

 
Copyright © 2013 American Chemical Society
 

January 21, 2013 Issue

Volume 91, Issue 3
09103-cover-pillwedge
January 21, 2013 Issue, Vol. 91 | Iss. 3
Subtherapeutic doses in drug development tests have shown important—but unanticipated—advantages
By Celia Henry Arnaud
(pp. 9-13)
Features
Government & Policy
 (pp. 20-25)
Science & Technology
Tetsuo Nozoe’s newly published collection of chemists’ signatures and structures showcases 41 years of vital science (pp. 28-29)
Back Issues
 

News of the Week

Global-Warming Warnings

Climate: Reports concur that human-induced changes are already leading to damaging environmental shifts
(p.4)

AstraZeneca’s R&D Overhaul

Pharmaceuticals: Research head Martin Mackay is out in leadership shake-up
(p.5)

Chemical Treatment Alleviates Nanotube Toxicity

Safety: Hydrophilic modifications render asbestos-like nanotube bundles harmless in mice
(p.5)

Energy Department Announces Radioactive Waste Strategy

Nuclear: Plan calls for interim storage site by 2021, geologic repository by 2048
(p.6)

Polysilicon Makers Cut Production, Lay Off Workers

Solar glut: Low prices and tariff threats force reduction in raw material manufacturing
(p.6)

Faster Membrane Gas Separations

Industrial: New polymer membranes lock in porosity, enhancing selectivity and permeability
(p.7)

Fiscal 2014 Federal Budget Delayed

Amid a stew of fiscal issues, the White House says rollout of spending plan will be delayed
(p.7)

Cubelike DNA Visualized In Cells

Drug Discovery: Elusive drug targets called G-quadruplexes confirmed in human DNA
(p.8)

M&G Picks Sinopec To Build Polyester Plant

Billion dollar project in Texas unites several foreign partners
(p.8)
 

Departments

09103-scitech1-Toddsigningcxd

Science & Technology

Tetsuo Nozoe’s newly published collection of chemists’ signatures and structures showcases 41 years of vital science
(pp. 28-29)
Subtherapeutic doses in drug development tests have shown important—but unanticipated—advantages
(pp. 9-13)
Researchers reveal troubling practices and perceptions in laboratories
(pp. 30-31)

Editor's Page